10.2024
Our partner Dede Willis will be presenting the Harry William Lee Porth Distinguished Lecture at Missouri University of Science and Technology. Her talk is titled “From Lab to Market: Commercializing University Life Science Innovations" and will describe how to translate groundbreaking life science research into viable market solutions, navigating the journey from lab to commercial success, whilst avoiding common pitfalls. For more information, please go to https://calendar.mst.edu/event/dede-willis-porth-distinguished-lecture-series
09.2023
Ventac Partners will sit on an investor panel at the LSX World Congress USA to be held this September in Boston. Please reach out to partners Robert Buchanan or Randy Berholtz with any questions you may have or if you wish to meet during the conference.
https://www.lsxleaders.com/lsx-usa-congress
03.2021
The 17th edition of Ventac Partners' week-long “Build a Biotech” course at the Norwegian University of Science and Technology (NTNU) took place in mid-March. A record 71 bioscience, medical and entrepreneurship students, plus tech transfer staff, developed 10 biotech, bioinformatics and medtech cases into viable and investable businesses. This was the second time the course has been run online. Group interaction was good and the teams’ understanding and output was excellent. We look forward to delivering the next edition of the course in person.
11.2020
APIM Therapeutics will be participating at the Global Pharmaceutical and Biotechnology Conference, 9th - 11th November 2020
04.2020
The 16th edition of Ventac Partners' week-long “Build a Biotech” course at the Norwegian University of Science and Technology (NTNU) has taken place this month. 59 students in teams developed 9 technology cases into businesses. This was the first time the course has been run online.
01.2020
Ventac Partners M. Oerum, Scott Woodward, Dede Willis and Randy Berholtz will be attending the 38th Annual J.P. Morgan Healthcare Conference, San Francisco, USA, 13-16 January 2020.
06.2019
Ventac portfolio companies Coegin Pharma (formerly Avexxin) and APIM Therapeutics will be attending the BIO Annual Meeting in Philadelphia, USA.